TESARO Joins Healthcare Businesswomen’s Association as Corporate Partner

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to support the Healthcare Businesswomen’s Association (HBA) as a Corporate Partner. HBA is the leading global organization committed to furthering the advancement and impact of women in healthcare. The organization accomplishes its mission … [Read more...]

Share buy-back week 25/2017

Announcement              26 June 2017   Coloplast – transactions in connection with share buy-back programme  As mentioned in Announcement No. 2/2017 Coloplast has initiated the second part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to … [Read more...]

Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA

Valby, Denmark and Osaka, Japan, 23 June 2017 - H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) today announced that after providing additional analysis, the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the supplemental new drug application (sNDA) to include new data in the clinical trials section of … [Read more...]

Vladimirs Krusinskis Appointed As the New Board Member of Olainfarm

Olaine, 2017-06-22 14:50 CEST (GLOBE NEWSWIRE) -- Vladimirs Krusinskis is a Director of Tehcnical Department of AS “Olainfarm”, having more than 15 years of experience in industrial companies. Mr. Krusinskis joined Olainfarm in 2012. His previous career included AS “Rigas Farmaceitiska Fabrika”. Vladimirs Krusinskis has a degree of Bachelor of Engineering. Mr. Krusinskis owns … [Read more...]